Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor maintenance update to the site’s revision labeling.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3 in the revision history. This indicates an updated version of the page being presented.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page footer now displays Revision: v3.6.3 instead of Revision: v3.6.2, indicating a minor site version update.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s revision identifier was updated from v3.6.0 to v3.6.2, indicating a small metadata update to the page’s version tag.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded a recruitment-status note indicating enrollment has ceased, and introduced new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with a site revision tag 'Revision: v3.6.0'.SummaryDifference0.5%

- Check79 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a new version of the content.SummaryDifference0.0%

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.